New Delhi, Feb 10 (IANS) AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to sell and distribute Durvalumab solution for infusion used in cancer treatment for an additional indication.In its latest stock exchange filing, the drug company said that through this approval, “Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or rec…
Trending
- Sheena Chohan Exclusive: From Global Cinema to Human Rights Advocacy, The Actress Redefining Purpose-Driven Stardom
- Lo Naveena Review: Humour, Heartbreak, and Friendship Shine in This Charming Kannada Entertainer
- Sattendru Maarudhu Vaanilai Review: Jai and Meenakshi Govindarajan Deliver a Wildly Entertaining Tamil Thriller You Cannot Miss
- Shikhandi (2026) Review: A Riveting Paranormal Thriller That Awakens Ancient Legends
- Sherr (2026) Movie Review: A Raw Kannada Crime Drama That Packs a Punch
- Mr. Work From Home Review: Trigun’s Bold Leap From Silicon Valley to Soil Strikes a Meaningful Chord
- Harudu (2026) Review: Venkat’s Gritty Cop Drama Delivers Raw Action and Solid Entertainment
- Kartavya Review: Saif Ali Khan Delivers a Gripping Performance in This Bold Caste-Crime Thriller on Netflix